Clinical efficacy and safety of fucoidan for biochemical recurrence after radical prostatectomy
Phase 2
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000005432
- Lead Sponsor
- Dept. of Urology, Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) undergoing hormonal therapy 2) suspecting of distant metastasis 3) severe comorbidities 4) during 3 mo. before attempt of fucoidan intervention, receiving any types of complementary/alternative medicine 5) inappropriate, judged by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Partial regression rate accoriding to PSA level, at 6mo. after intervention
- Secondary Outcome Measures
Name Time Method 1) rate of improvement of PSA slope,, at 6mo. after intervention 2) alteration of testosterone level 3) safety